Use of osteopontin for the treatment and/or prevention of neurologic diseases
Patent Number: 7,297,099
Date of First Priority Issue: Thursday May 17th, 2001
Date Issued: Tuesday November 20th, 2007
Assignee: Laboratoires Serono SA (Coinsins, Vaud, CH)
Inventors: Boschert; Ursula (Troinex, CH), Feger; Georg (Thoiry, FR), Selvaraju; Raghuram (Vandoeuvres, CH), Bernasconi; Lilia (Perly, CH), Papoian; Ruben (Cincinnati, OH)
From Class: Use
Comments: No comments
Osteopontin is a cytokine molecule that is involved in tumor metastasis and various immune functions.
In the current invention, osteopontin is used to treat chemotherapy-induced neurotoxicity. This is essentially a next step from the previous work of the same inventors who previously patented the use of osteopontin for remyelination.
View this patent on the USPTO website.
Added to StemCellPatents.com on Sunday November 25th, 2007
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.